An In-Depth Examination of Formularies and Other Features of Medicare Drug Plans

An In-Depth Examination of Formularies and Other Features of Medicare Drug Plans

Variations within prescription drug plans have major implications for how forty-two million Medicare beneficiaries access needed medications and handle out-of-pocket costs, a new report from the Henry J. Kaiser Family Foundation argues. The report, An In-Depth Examination of Formularies and Other Features of Medicare Drug Plans (58 pages, PDF), assesses the formularies, costs, and drug-use management tools of the fourteen organizations that account for most stand-alone drug plans and cautions beneficiaries to choose carefully among them.